Adverse Drug Reactions Monitoring in Inpatients department of tertiary care Teaching Hospital
Keywords:
Adverse drug reactions, WHO, Naranjo scale, ADRAbstract
Introduction and Objectives: The aim of study was to detect, document and to do causality analysis of ADRs in In-patients of tertiary care teaching hospital. Method: It is a prospective observational study being conducted in a tertiary care hospital of central India. In addition to spontaneous voluntary reporting system, an active search was also used to collect ADRs. The data collected was recorded on standard ADR reporting forms. Each reported form was then assessed for its causality and severity as per the standard criteria. Results: A total of 171 ADRs in 126 patients were detected. Out of which 66.1% ADRs occurred in males and 33.9% ADRs in females. Majority of the ADRs were related to the gastro-intestinal system (50.29%), with vomiting and nausea being the most common. Maximum number of ADRs were due to Antitubercular drugs (58.48%). The causality assessment as per Naranjo’s scale showed that out of 171 ADRs, 98.83% were probable and 1.16% were possibly due to drug use. According to the WHO probability assessment scale, 66.66% were in possible and 33.33% ADRs were in probable categories respectively. Severity assessment by modified Hartwig and Siegel scale showed that 74.27% ADRs were mild and 25.73% were moderate. Conclusion: Considering the magnitude of ADRs related problems, there is a need for greater awareness among health care professionals to detect and report them. These ADRs if recognised in time and managed properly can prevent treatment interruption.
References
World Health Organization. Safety of medicines - A guide to detecting and reporting adverse drug reactions - Why health professionals need to take actions. Geneva: World Health Organization. Available at: http://apps.who.int/medicinedocs/en/d/Jh2992e/6.html. 2002.
Committee on Quality of Health Care in America: Institute of Medicine. To err is human: building a safer health system. Washington, D.C.: National Academy Press; 2000. 2
Lazarou J, Pomeranz B, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A metaanalysis of prospective studies. JAMA1998;279:1200– 1205.
Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000;109(2):87–94.
Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med1995;155(18):1949–1956.
Leape LL, Brennan TA Laird N, Lawthers AG ,Localio AR, Barnes BA et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J. Med 1991;324(6):377–384.
Classen DC , Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997;277(4):301–306.
Friedman MA, Woodcock J, Lumpkin MM, Shuren JE, Hass AE, Thompson LJ. The safety of newly approved medicines: do recent market removals mean there is a problem? JAMA 1999; 281(18):1728–1734.
Frattarelli DAC. Adverse drug reactions and avalanches:life at the edge of chaos.J.Clin. Pharmacol.2005;45;866.
Miller RR: Hospital admissions due to adverse drug reactions: A report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med 1974;134:219- 223
Talley RB, Laventurier MF: Drug induced illness. JAMA 1974;229:1043.
Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol1996;42:423-9.
Christopher FG, David RM, Philip HR, Adrin MB. Adverse drug reaction monitoring by United Kingdom hospital. pharmacy department: impact of the introduction of ‘yellow card’ reporting for pharmacists. International Journal of pharmacy practice 1999;7:238-46.
Dhasmana DC, Seth V, Mishra KC, Voluntary adverse drug reaction reporting in a tertiary care teaching hospital. Indian Journal of Pharmacology 2002;34:204-5
Daphene Y, Marthe P et al. Incidence of serious side effects from first line antituberculosis drug among patients treated for Active TB. Am J Resp Crit Care Med 2003:167;1472-7.
Arulmani R, Rajendran S D, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. British Journal of Clinical Pharmacology.2007;65:2/210-216.
Gupta R, Sheikh A, Strachan D, Anderson HR. Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data. BMJ 2003;327(7424):1142-3.
Sriram Shanmugam, Ghasemi Ali, Ramasamy Rajeswari, Devi Manjula, Balasubramanian Rajalingam, Ravi Thengungal Kochupapy, Sabzghabaee Ali Mohamad.JRMS ,2011;16(1):16-25.
Pundit J, Parthasarathy G, Ramesh M, Adverse drug reactions in a south Indian teaching hospital-their severity and cost involved. Pharmacoepidemiology and drug safety2003 Dec;12(8):687-92.
Suh DC, Woodall B S, Shin S K, Hermes-De, Santis ER, Clinical and economic impact of adverse drug reactions in hospitalized patients. The Annals of Pharmacotherapy 2000;34(12):1373-9
Dhingra VK, Rajpal S, Aggarwal N, Aggarwaln JK, Shadab K, Jain SK. Adverse drug reactions observed during DOTS. J Commun Dis 2004;36:251-9.
Murphy BM, Frigo LC. Development, implementation and results of a successful multidisciplinary adverse drug reactions reporting program in a University teaching hospital. Hosp Pharm 1993; 28: 1199–204.
Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a pilot study. J Clin Phar Ther 2006;31(4):335-41.
Shuster J. ISMP adverse drug reactions. Hosp Pharm 2009; 44(8):658-61.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Biomedical Review follows the Creative Commons CC-BY license (Attribution). It means Authors can use, reuse and build upon the material published in the journal but only for non-commercial purposes. Every article published in the Journal clearly mentioned licensing terms between author/authors and publisher (Siddharth Health Research and Social Welfare Society) as the logo of Creative Commons CC-BY license (Attribution) https://creativecommons.org/licenses/by/4.0/.